Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (Review)

By    

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3212-3218

Spandidos Publications

Access to resources Recommend Favorite

Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factorκB ligand in osteoblasts in vivo and in vitro

By          

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 769-777

Spandidos Publications

Access to resources Recommend Favorite

Receptor activator of nuclear factor κB expression is a prognostic factor in human osteosarcoma

By    

Oncology Letters, Vol. 10, Iss. 3, 2015-01 ,pp. : 1813-1815

Spandidos Publications

Access to resources Recommend Favorite

Mycobacterium tuberculosis 10-kDa co-chaperonin regulates the expression levels of receptor activator of nuclear factor-κB ligand and osteoprotegerin in human osteoblasts

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 3, 2015-01 ,pp. : 919-924

Spandidos Publications

Access to resources Recommend Favorite

Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-κB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton

By Mountzios Giannis   Dimopoulos Meletios-Athanassios   Bamias Aristotelis   Papadopoulos George   Kastritis Efstathios   Syrigos Konstantinos   Pavlakis George   Terpos Evangelos  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 221-229

Informa Healthcare

Access to resources Recommend Favorite